Lupus

Aerobic capacity and cardiovascular risk both improve when people with systemic lupus erythematosus (SLE) exercise regularly, according to a new systematic review.

The data could help clinicians better identify patients who are good fits for belimumab after rituximab.

Medical experts illustrate characteristics in the presentation of lupus nephritis.

Alvin Wells, MD, PhD, opens a discussion surrounding systemic lupus erythematosus (SLE) and lupus nephritis (LN).

A systematic review and meta-analysis presented at ACR Convergence 2022 provide insight into the effects of belimumab in patient populations with cutaneous lupus erythematosus, with or without systemic lupus erythematosus (SLE).

Authors also found that the mortality rate of people with cutaneous lupus erythematosus (CLE) are generally similar to that of the general population.

Liz Lightstone, MBBS, PhD, FRCP, professor of renal medicine for the faculty of medicine, Imperial College London, discussed recently approved therapeutic options for patients with lupus nephritis and what unmet needs persist in the management of the disease.

Colombia and Brazil had the highest prevalence and incidence of systemic lupus erythematosus (SLE), a new investigation found.

A new report found interesting links between genetic factors associated with COVID-19 severity and autoimmune disease among persons who have systemic lupus erythematosus (SLE).

Existing evidence suggests genetics, environmental factors, and exposure to specific chemicals—such as those in cigarettes—can all increase a person’s risk of systemic lupus erythematosus.

These new study data are based on 20 years of follow-up in 92 Chinese children with lupus nephritis.

Blacks and Hispanics with systemic lupus erythematosus (SLE) are more than twice as likely to have severe outcomes from COVID-19 compared with White patients with SLE, a new study has found.

Data suggest incidence and prevalence of systemic lupus erythematosus (SLE) vary widely among regions, although the authors noted some regions have been studied more extensively than others.

Only about 10 cases of hypoparathyroidism related to systemic lupus erythematosus (SLE) have been reported, according to researchers who recently described such a case.

However, the researchers said their findings should not be interpreted as completely refuting the possibility that hydroxychloroquine might be a useful tool in preventing or slowing the development of systemic lupus erythematosus (SLE).

The question of whether bone erosion is a feature of Jaccoud arthropathy has remained controversial among persons who have systemic lupus erythematosus (SLE).

The research shows a disease-specific quality-of-life (QOL) tool is more sensitive than a generic version.

The patient was successfully treated with rituximab and intravenous immunoglobulin.

The case involved a 69-year-old man who presented with lupus nephritis.

A new review article explains the role of biologics in treatment systemic lupus erythematosus (SLE) and lupus nephritis.

New data show litifilimab outperformed placebo in patients with active arthritis and skin manifestations due to systemic lupus erythematosus (SLE).

The authors found the association by comparing echocardiographic and biochemical changes after 5 years in patients with systemic lupus erythematosus (SLE).

A new study finds anxiety and depression are more common in people with systemic lupus erythematosus (SLE) if they also have nephritis.

The findings mean it may be feasible to use adult systemic lupus nephritis (SLE) trial data to reduce the data needed for pediatric indications.

The use of existing guidelines for pediatric treatment varies significantly among sites, a new study has found.

A new review outlines what is known about cardiovascular disease (CVD) risk in patients with systemic lupus erythematosus (SLE) and how that might affect patient care.